PMID- 38055375 OWN - NLM STAT- MEDLINE DCOM- 20231211 LR - 20240110 IS - 1678-9946 (Electronic) IS - 0036-4665 (Print) IS - 0036-4665 (Linking) VI - 65 DP - 2023 TI - Can COVID-19 impact the natural history of paracoccidioidomycosis? Insights from an atypical chronic form of the mycosis. PG - e57 LID - S0036-46652023000100224 [pii] LID - 10.1590/S1678-9946202365057 [doi] LID - e57 AB - Paracoccidioidomycosis (PCM) is a systemic fungal infection caused by Paracoccidioides spp. It can occur as an acute/subacute form (A/SAF), a chronic form (CF) and rarely as a mixed form combining the features of the two aforementioned forms in an immunocompromised patient. Here, we report a 56-year-old male patient with CF-PCM who presented with atypical manifestations, including the development of an initial esophageal ulcer, followed by central nervous system (CNS) lesions and cervical and abdominal lymphatic involvement concomitant with severe SARS-CoV-2 infection. He was HIV-negative and had no other signs of previous immunodeficiency. Biopsy of the ulcer confirmed its mycotic etiology. He was hospitalized for treatment of COVID-19 and required supplemental oxygen in the intensive unit. The patient recovered without the need for invasive ventilatory support. Investigation of the extent of disease during hospitalization revealed severe lymphatic involvement typical of A/SAF, although the patient;s long history of high-risk exposure to PCM, and lung involvement typical of the CF. Esophageal involvement is rare in non-immunosuppressed PCM patients. CNS involvement is also rare. We suggest that the immunological imbalance caused by the severe COVID-19 infection may have contributed to the patient developing atypical severe CF, which resembles the PCM mixed form of immunosuppressed patients. Severe COVID-19 infection is known to impair the cell-mediated immune response, including the antiviral response, through T-lymphopenia, decreased NK cell counts and T-cell exhaustion. We hypothesize that these alterations would also impair antifungal defenses. Our case highlights the potential influence of COVID-19 on the course of PCM. Fortunately, the patient was timely treated for both diseases, evolving favorably. FAU - Souza, Cesar Augusto Tomaz de AU - Souza CAT AUID- ORCID: 0000-0003-1413-4918 AD - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil. FAU - Ponce, Cesar Cilento AU - Ponce CC AD - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil. AD - Instituto Adolfo Lutz, Sao Paulo, Sao Paulo, Brazil. FAU - Klautau, Gisele Burlamaqui AU - Klautau GB AD - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil. AD - Santa Casa de Sao Paulo, Faculdade de Medicina, Sao Paulo, Sao Paulo, Brazil. FAU - Marques, Nathan Costa AU - Marques NC AD - Universidade de Sao Paulo, Faculdade de Medicina, Departamento de Cardio-Pneumologia, Sao Paulo, Sao Paulo, Brazil. FAU - Queiroz, Wladimir AU - Queiroz W AD - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil. FAU - Patzina, Rosely Antunes AU - Patzina RA AD - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil. FAU - Benard, Gil AU - Benard G AUID- ORCID: 0000-0002-5469-3602 AD - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Laboratorio de Micologia Medica (LIM-53), Sao Paulo, Sao Paulo, Brazil. FAU - Lindoso, Jose Angelo Lauletta AU - Lindoso JAL AUID- ORCID: 0000-0002-4405-4401 AD - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil. AD - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Laboratorio de Protozoologia (LIM-49), Sao Paulo, Sao Paulo, Brazil. LA - eng PT - Case Reports PT - Journal Article DEP - 20231201 PL - Brazil TA - Rev Inst Med Trop Sao Paulo JT - Revista do Instituto de Medicina Tropical de Sao Paulo JID - 7507484 RN - 0 (Antifungal Agents) SB - IM EIN - Rev Inst Med Trop Sao Paulo. 2024 Jan 05;66:e57err. PMID: 38198379 MH - Male MH - Humans MH - Middle Aged MH - *Paracoccidioidomycosis/complications/diagnosis MH - Ulcer MH - *COVID-19/complications MH - SARS-CoV-2 MH - Antifungal Agents/therapeutic use MH - *Paracoccidioides PMC - PMC10691805 COIS- CONFLICT OF INTERESTS The authors declare that they have no conflict of interests. EDAT- 2023/12/06 18:42 MHDA- 2023/12/11 12:43 PMCR- 2023/12/01 CRDT- 2023/12/06 12:43 PHST- 2023/08/21 00:00 [received] PHST- 2023/10/10 00:00 [accepted] PHST- 2023/12/11 12:43 [medline] PHST- 2023/12/06 18:42 [pubmed] PHST- 2023/12/06 12:43 [entrez] PHST- 2023/12/01 00:00 [pmc-release] AID - S0036-46652023000100224 [pii] AID - 10.1590/S1678-9946202365057 [doi] PST - epublish SO - Rev Inst Med Trop Sao Paulo. 2023 Dec 1;65:e57. doi: 10.1590/S1678-9946202365057. eCollection 2023.